This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delos, S. E.
Right arrow Articles by White, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delos, S. E.
Right arrow Articles by White, J. M.

 Previous Article  |  Next Article 

Journal of Virology, October 2000, p. 9738-9741, Vol. 74, No. 20
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Critical Role for the Cysteines Flanking the Internal Fusion Peptide of Avian Sarcoma/Leukosis Virus Envelope Glycoprotein

S. E. Delos* and J. M. White

Department of Cell Biology, School of Medicine, University of Virginia Health System, Charlottesville, Virginia 22908

Received 11 April 2000/Accepted 28 July 2000

The transmembrane subunit (TM) of the envelope glycoprotein (Env) of the oncovirus avian sarcoma/leukosis virus (ASLV) contains an internal fusion peptide flanked by two cysteines (C9 and C45). These cysteines, as well as an analogous pair in the Ebola virus GP glycoprotein, are predicted to be joined by a disulfide bond. To examine the importance of these cysteines, we mutated C9 and C45 in the ASLV subtype A Env (EnvA), individually and together, to serine. All of the mutant EnvAs formed trimers that were composed of the proteolytically processed surface (SU) and TM subunits. All mutant EnvAs were incorporated into murine leukemia virus pseudotyped virions and bound receptor with wild-type affinity. Nonetheless, all mutant EnvAs were significantly impaired (~1,000-fold) in their ability to support infectivity. They were also significantly impaired in their ability to mediate cell-cell fusion. Our data are consistent with a model in which the internal fusion peptide of ASLV-A EnvA exists as a loop that is stabilized by a disulfide bond at its base and in which this stabilized loop serves an important function during virus-cell fusion. The fusion peptide of the Ebola virus GP glycoprotein may conform to a similar structure.


* Corresponding author. Mailing address: Department of Cell Biology, University of Virginia Health System, School of Medicine, P.O. Box 800732, Charlottesville, VA 22908-0732. Phone: (804) 924-2009. Fax: (804) 982-3912. E-mail: sed7a{at}unix.mail.virginia.edu.


Journal of Virology, October 2000, p. 9738-9741, Vol. 74, No. 20
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Melder, D. C., Yin, X., Delos, S. E., Federspiel, M. J. (2009). A Charged Second-Site Mutation in the Fusion Peptide Rescues Replication of a Mutant Avian Sarcoma and Leukosis Virus Lacking Critical Cysteine Residues Flanking the Internal Fusion Domain. J. Virol. 83: 8575-8586 [Abstract] [Full Text]  
  • Nelson, G. E., Wagenaar, T. R., Moss, B. (2008). A Conserved Sequence within the H2 Subunit of the Vaccinia Virus Entry/Fusion Complex Is Important for Interaction with the A28 Subunit and Infectivity. J. Virol. 82: 6244-6250 [Abstract] [Full Text]  
  • Delos, S. E., Brecher, M. B., Chen, Z., Melder, D. C., Federspiel, M. J., White, J. M. (2008). Cysteines Flanking the Internal Fusion Peptide Are Required for the Avian Sarcoma/Leukosis Virus Glycoprotein To Mediate the Lipid Mixing Stage of Fusion with High Efficiency. J. Virol. 82: 3131-3134 [Abstract] [Full Text]  
  • Contreras-Alcantara, S., Godby, J. A., Delos, S. E. (2006). The Single Ligand-binding Repeat of Tva, a Low Density Lipoprotein Receptor-related Protein, Contains Two Ligand-binding Surfaces. J. Biol. Chem. 281: 22827-22838 [Abstract] [Full Text]  
  • Amberg, S. M., Netter, R. C., Simmons, G., Bates, P. (2006). Expanded Tropism and Altered Activation of a Retroviral Glycoprotein Resistant to an Entry Inhibitor Peptide. J. Virol. 80: 353-359 [Abstract] [Full Text]  
  • Cheng, L. T., Plemper, R. K., Compans, R. W. (2005). Atypical Fusion Peptide of Nelson Bay Virus Fusion-Associated Small Transmembrane Protein. J. Virol. 79: 1853-1860 [Abstract] [Full Text]  
  • Vigdorovich, V., Strong, R. K., Miller, A. D. (2005). Expression and Characterization of a Soluble, Active Form of the Jaagsiekte Sheep Retrovirus Receptor, Hyal2. J. Virol. 79: 79-86 [Abstract] [Full Text]  
  • Matsuyama, S., Delos, S. E., White, J. M. (2004). Sequential Roles of Receptor Binding and Low pH in Forming Prehairpin and Hairpin Conformations of a Retroviral Envelope Glycoprotein. J. Virol. 78: 8201-8209 [Abstract] [Full Text]  
  • Shmulevitz, M., Epand, R. F., Epand, R. M., Duncan, R. (2004). Structural and Functional Properties of an Unusual Internal Fusion Peptide in a Nonenveloped Virus Membrane Fusion Protein. J. Virol. 78: 2808-2818 [Abstract] [Full Text]  
  • Earp, L. J., Delos, S. E., Netter, R. C., Bates, P., White, J. M. (2003). The Avian Retrovirus Avian Sarcoma/Leukosis Virus Subtype A Reaches the Lipid Mixing Stage of Fusion at Neutral pH. J. Virol. 77: 3058-3066 [Abstract] [Full Text]  
  • Jeffers, S. A., Sanders, D. A., Sanchez, A. (2002). Covalent Modifications of the Ebola Virus Glycoprotein. J. Virol. 76: 12463-12472 [Abstract] [Full Text]  
  • Gibbons, D. L., Kielian, M. (2002). Molecular Dissection of the Semliki Forest Virus Homotrimer Reveals Two Functionally Distinct Regions of the Fusion Protein. J. Virol. 76: 1194-1205 [Abstract] [Full Text]  
  • Allison, S. L., Schalich, J., Stiasny, K., Mandl, C. W., Heinz, F. X. (2001). Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E. J. Virol. 75: 4268-4275 [Abstract] [Full Text]